Prophylactic granulocyte colony-stimulating factor treatment for acquired chronic severe neutropenia in pregnancy.
Sangalli
M R
MR
Canberra Clinical School, Department of Obstetrics and Gynaecology, Canberra Hospital, Australian Capital Territory, Australia.
Peek
M
M
McDonald
A
A
D000328:Adult; D002908:Chronic Disease; D004334:Drug Administration Schedule; D005260:Female; D000069585:Filgrastim; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D009503:Neutropenia / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy* / Q000473:pathology; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy* / Q000473:pathology; D011263:Pregnancy Trimester, Third; D011994:Recombinant Proteins; D012720:Severity of Illness Index
D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D000069585:Filgrastim